Immutep Limited (IMMP)
Nasdaq: IMMP · Pharmaceutical Preparations · Sydney,, AU · filing with the SEC since 2012
Income statement, as filed
In Australian dollars (AUD), as filed; per-share figures in Australian dollars; share counts. The fiscal year ends in June.The Form 20-F filed Oct 23, 2026 for the period ended Jun 30, 2026 is not in EDGAR's company facts yet; its figures print once EDGAR carries them.
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
ifrs-full:RevenueResearch and development spent on inventing what it sells next
ifrs-full:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
ifrs-full:GeneralAndAdministrativeExpenseFinance costs what its borrowing cost
ifrs-full:FinanceCostsInterest income what its cash and investments earned
ifrs-full:RevenueFromInterestIncome before income taxes profit before tax
ifrs-full:ProfitLossBeforeTaxIncome tax expense tax charged on the period's profit
ifrs-full:IncomeTaxExpenseContinuingOperationsNet income the whole group's profit, minority holders' share included
ifrs-full:ProfitLossNet income to shareholders the profit or loss that belongs to the company's shareholders
ifrs-full:ProfitLossAttributableToOwnersOfParentEarnings per share, basic net income per share outstanding
ifrs-full:BasicEarningsLossPerShareEarnings per share, diluted net income per share, counting every share that could be issued
ifrs-full:DilutedEarningsLossPerShareWeighted average shares, basic the average count of shares outstanding
ifrs-full:WeightedAverageSharesWeighted average shares, diluted the average count with every share that could be issued
ifrs-full:AdjustedWeightedAverageShares